RDB07861 - pGL3-AID R4 del.-07

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.

Terms and conditions set forth by the DEPOSITOR	In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature(s) designated by the DEPOSITOR is requested. (Nat. Immunol., 11, 148-154 (2010)). In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE.
Additional terms and conditions for distribution	The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
Ordering	Please visit Information of Request for Distribution.[link] Order form [Credit Card Payment] [Bank Transfer Payment] Material Transfer Agreement (MTA for use for not-for-profit academic purpose) [Word]

提供案内 (日本国内)

[open/close]

提供条件	利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する (Nat. Immunol., 11, 148-154 (2010))。利用者は、研究成果の公表にあたって謝辞の表明を必要とする。　学術機関の学術研究に限る。　営利機関の利用希望者は、事前に利用条件等につき寄託者と合意し、提供承諾を得ること。　利用者が本件リソースを使用して得られた研究成果に基づき特許等の申請、及び事業活動を行う場合は、寄託者と別途協議を行う。
付加的提供条件	本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。
提供依頼	手続きの詳細は、「提供申込みについて[link]」をご覧ください。提供依頼書 [Word] 提供同意書 (MTA、非営利機関による非営利学術研究用)[Word]

References and tips

Sequence information

Catalog #	Resource name	Shipping form	Fee (non-profit org.)
RDB07861	pGL3-AID R4 del.-07	DNA solution

original	Tran, T.H., B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers. Nat. Immunol., 11, 148-154 (2010). PMID 19966806.

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by check

icon as well as clone information before placing your order.

Primer: pGL4-4174F Sequence file: RDB07861_A4Gia.seq
>07861_07861_A4Gi_pGL4-4174F_G01_19.ab1 1 TGGGTCAGAA CATTTCTCTA TCGATAGGTA CCCAGGCGAC TCGATTTCCA AGTCACAGTA 61 TTTTTGGTTA AAAACAATGT GACCAAGTTG GCTTGTGGTT TTTCAATAGA AGTTAATGAG 121 GGGAAAGAGA AGTTAATGAA GAAAATAAAA GTTGATCAAA ACCCTGTAAA CTGCTTTGCC 181 GCTGTACCAG TTCCAAATTT CCCGGGACTG GAAAATGGTT TTTGTAACTA AGTGAGATCT 241 CTTTCCTTCC TTTAGAAGAA GGCAAATGAG AGAATTTGGC TTTCTTACAA ATCAAGGGTT 301 TTGTATTTGT TCCTATGGCA TGTGTACGGC ATCTGTAAGA GAGGGTGTGG GCGTGCGTGT 361 GCGTGTGCTA CAGCTCGAGT TTAGAGGAAC AGCCTCGAAG GAAGTTGGAC ATTAAGCATG 421 AGCAGAACTG GCCCCCCCCC CCAATCATTT AATCCGTGTG GCTTTGCCCA CACGGGCAAA 481 AAAATCCCCT CTCGCCCCCC CGGTGGCCGC CCGGCCAGAA ATTTTTTTTT TTTTTTTTTT 541 TTTTTTTTTT GGGGTTGGGG GGGGGGGGGC CCCCCCCCCC CCCCCCCAAA AAAAAAAAAA 601 AAAAAAAGAG AAAGTTAATT TCCCCCCCCC CCTCCCCGGG GGGGAGGGGG TTTTTTTTTT 661 TTTTTTCTCT GCGGGGGGGG GGGGGGGGGG GGGGGGGGCC CCCCACCAAC AACAAAACAA 721 CAAACAAAAA AAATAAAAAT ATAAGTATTT TTTTTTTTTT TTTTGTGTGG GGGGGGGGGG 781 GGGGGGGGGG GTGTGGGTCG TCTCTTCTCC CTCTCCCCCC CACAACACCA AACACAAACA 841 AAACAAAAAA ACGAGACGAA GTGGAGAGGA GGCATACAAG AGGGCTGCGT GCTCTTCGTC 901 TTTTTTTTTT TTGCATGGGG CGAGAGAAAA AAAAAGAAGA AAAAAAGAGA AGGGGTGGAG 961 ATCAGTCATG CTGGCTCCGT CTCTACAGCA CCAACAAGAA AAACAGACCA CATGAGTACG 1021 TGAGACGGAC TGGCGCGAGC CTGCGTCTGA TCGGATGCTT TTCGTAATGT TCCATTGTGC 1081 TCTTACTGGA GGTTTGATTT GGGGATAGGT GGAGTTAGGA AGGGGTGGAG TAGTAGGCAG 1141 AGGGGGAATG AGACATTCAG CATCATAAAA CGGAAATAAA ACAAGTGCAT AAATGAGCAA 1201 TAACAG //
Primer: Luc_R Sequence file: RDB07861_A4Gib.seq
>07861_07861_A4Gi_Luc_R_H01_22.ab1 1 GTTGATTCAG GGACAGGGCG TATCTCTTCA TAGCCTTATG CAGTTGCTCT CCAGCGGTTC 61 CATCTTCCAG CGGATAGAAT GGCGCCGGGC CTTTCTTTAT GTTTTTGGCG TCTTCCATGG 121 ATCGGTCTCC AGCGTGACTT TCTTGACTCC CTCAAAGTCT TAGGCCAAAG GAAGCTTGCT 181 TCAAGCAAGG CTGCTTCAGT GCTGTTGTGT GACAGAGCAC TGGCCCCTGG CATTCAAATC 241 TGAGCTTGCT CTTGTGGGCT CCTCCCCCAC GACAGCATCA CTACCACCAG GTATCCAACA 301 TCTGCCTCCT GGGTTGGGTC CAGTAAAGAT GGGCGGGGCT GTGGTGGGCA AAGCCACACG 361 GATTAAATGA TTGGGGGGGG GGGCCAGTTC TGCTCATGCT TAATGTCCAA CTTCCTTCGA 421 GGCTGTTCCT CTAAACTCGA GCTGTAGCAC ACGCACACGC ACGCCCACAC CCTCTCTTAC 481 AGATGCCGTA CACATGCCAT AGGAACAAAT ACAAAACCCT TGATTTGTAA GAAAGCCAAA 541 TTCTCTCATT TGCCTTCTTC TAAAGGAAGG AAAGAGATCT CACTTAGTTA CAAAAACCAT 601 TTTCCAGTCC CGGGAAATTT GGAACTGGTA CAGCGGCAAA GCAGTTTACA GGGTTTTGAT 661 CAACTTTTAT TTTCTTCATT AACTTCTCTT TCCCCTCATT AACTTCTATT GAAAAACCAC 721 AAGCCAACTT GGTCACATTG TTTTTAACCA AAAATACTGT GACTTGGAAA TCGAGTCGCC 781 TGGGTACCTA TCGATAGAGA AATGTTCTGG CACCTGCACT TGCACTGGGG ACAGCCTATT 841 TTGCTAGTTT GTTTTGTTTC GTTTTGTTTT GATGGAGAGC GTATGTTAGT ACTATCGATT 901 CACACAAAAA ACCAACACAC AGATGTAATG AAAATAAAGA TATTTTATTG CGGCCGCTCC 961 AAGTACCTCC CGTACCTTTA ATATTACTTA CTTATCATGG TAGCTTGGGC TGGCGTAATA 1021 GCGAAGAGGC CCGCACGATC GCCCTTCCAC CAGTTGCGCA GCCTGGATTG CGATTGCAAT 1081 GTAGCGTTAT ATTTGTTAAT CGCGTGATTT TTGTTAAATT CAGCTCCA //

pGL3-AID R4 del.-07

Distribution information

References and tips

Sequence information

References